Regulatory expert and drug development professional, Josh Johnson has extensive experience in regulatory strategy, the development of pharmaceuticals, and communicating with the FDA. Having worked across multiple therapeutic areas, Johnson has acquired a diverse set of skills as a Regulatory Affairs Manager at Merz Pharma, Manager of US Regulatory Affairs R&D at Chiesi USA, Inc. and as a former Research Scientist and Postdoctoral Associate at Camargo Pharmaceutical Services and Duke University, respectively.

With a background in behavioral pharmacology/toxicology, quantitative models of behavior, and addiction, Johnson has developed a unique set of skills, poised to navigate the fast-paced pharmaceutical industry. He also holds a PhD and an MS in Experimental Psychology from Auburn University, where he was a Graduate Research Assistant/Doctoral Candidate, and a BS in Psychology and Spanish from Allegheny College.

Johnson has extensive experience in global regulatory affairs, serving as a regulatory lead for a sponsor, project lead, and as an expert in preparing regulatory documents such as INDs and NDAs. He has also been involved in preparing type A, B, and C meetings with the FDA and attending them across a wide range of therapeutic areas. Additionally, Johnson has served as an Adjunct Faculty at William Peace University, honing his communication and management skills.

Overall, Johnson is a seasoned regulatory professional, with years of experience under his belt, ready to tackle the hurdles of the pharmaceutical industry.